2-phenyl-3-heteroarylpropionic acid derivative or salt...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S461000, C549S501000, C548S377100

Reexamination Certificate

active

10489114

ABSTRACT:
The present invention relates to a 2-phenyl-3-heteroarylpropionic acid derivative or a salt thereof, and also relates to a pharmaceutical agent and a VLA-4 and/or LPAM-1 antagonist each of which contains the same as an active ingredient.

REFERENCES:
patent: 0293220 (1988-05-01), None
patent: 293220 (1988-11-01), None
patent: 1097596 (1968-01-01), None
patent: WO 98/08840 (1998-03-01), None
patent: WO 99/06433 (1999-02-01), None
patent: WO 99/62901 (1999-12-01), None
patent: WO 99/64390 (1999-12-01), None
Hcaplus 78:58183.
Durant et. al., “Nonsteroidal Antiinflammatory Agents. Some Arylacetic Acids”, Journal of Medicinal Chemistry (1965), 8(5), 598-603.
Hcaplus 143:95268.
Lobb et. al., “Small molecule antagonists of alpha 4 integrins: novel drugs for asthma”, Expert Opinion on Investigational Drugs (1999) 8(7):935-945.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-phenyl-3-heteroarylpropionic acid derivative or salt... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-phenyl-3-heteroarylpropionic acid derivative or salt..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-phenyl-3-heteroarylpropionic acid derivative or salt... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3936567

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.